Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: PLoS Genetics, 9, 3, S.

Ereignis
Veröffentlichung
(wo)
Augsburg, San Francisco
(wer)
Universität Augsburg, Public Library of Science
(wann)
2013
Urheber
Couch, F. J.
Wang, X.
Ditsch, Nina

DOI
10.1371/journal.pgen.1003212
URN
urn:nbn:de:bvb:384-opus4-843893
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
25.03.2025, 13:41 MEZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Couch, F. J.
  • Wang, X.
  • Ditsch, Nina
  • Universität Augsburg, Public Library of Science

Entstanden

  • 2013

Ähnliche Objekte (12)

Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen

Hochschulschrift

Prognostische Relevanz disseminierter CK18-positiver-Zellen im Knochenmark nodal-negativer Mammakarzinom-Patientinnen und Nachweis des Östrogenrezeptors (ÖR) auf disseminierten CK18-positiven-Zellen im Knochenmark von Mammakarzinom-Patientinnen

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers

Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

Prediction of breast and prostate cancer risks in male BRCA1 and BRCA2 mutation carriers using polygenic risk scores

P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer

P53 determines prognostic significance of the carbohydrate stem cell marker TF1 (CD176) in ovarian cancer

Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways

Thyroid hormone receptors predict prognosis in BRCA1 associated breast cancer in opposing ways

Germline RAD51C mutations confer susceptibility to ovarian cancer

Germline RAD51C mutations confer susceptibility to ovarian cancer

PET-CT in recurrent ovarian cancer: impact on treatment planning

PET-CT in recurrent ovarian cancer: impact on treatment planning

Verbundene Objekte